Project Grant R01AG082056

Award Date 6/1/24
Completion Date 3/31/29
Dollars Obligated $1.2M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
This $839,262 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a 5-year research study to investigate the effects of migration and acculturation on the risk of Alzheimer's disease and related dementias (ADRD) among Mexican Americans. The key objectives of the study are to: 1) estimate the impact of migration, US residence, and acculturation on cognitive function and dementia risk; 2) evaluate how immigration policy climates and social...
This $2,365,042 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to better understand the biological underpinnings of Alzheimer's disease and related dementias (ADRD). The award aims to leverage cross-national comparisons between the U.S. and India to evaluate biomarkers of neurodegeneration, vascular health, nutrition, and inflammation, and how they interface with social and economic factors. Key goals include classifying...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $767,193 to the University of California, Los Angeles (UCLA) to identify undiagnosed Alzheimer's disease (AD) cases, particularly within underserved Hispanic/Latino and non-Hispanic African American populations. The key objectives are to: 1) Identify disease trajectories associated with AD, 2) Utilize these disease trajectories and genetic data to predict undiagnosed AD cases, and 3)...
This federal Project Grant award R01AG084567, provided by the National Institute on Aging (CFDA 93.866 - Aging Research), supports a comprehensive study of cognitive decline and dementia in older first-generation immigrants from the Indian state of Kerala residing in the tri-state area of New York, New Jersey, and Connecticut. The $2,464,694 award, with a performance period from May 1, 2024 to February 28, 2029, aims to determine the role of immigrant and cultural factors, as well as social...
This federal Project Grant award in the amount of $2,201,136 was provided by the National Institute on Aging (NIA) under the NIA Aging Research program (CFDA 93.866) to The Trustees of Columbia University in the City of New York. The award aims to improve the understanding of Alzheimer's disease (AD) and related dementias (ADRD) by developing a comprehensive view of their genetic architecture. The project will leverage large-scale biobanks and electronic medical records to systematically study...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $311,341 to the University of Southern California to assess cost-associated barriers to the use of novel Alzheimer's and dementia therapeutics among older Hispanic or Latino adults. The project will conduct semi-structured interviews with a cohort of Latino adults and Latino patients with Alzheimer's/dementia and their caregivers. This qualitative research will inform a subsequent population-based...
The National Institute on Aging awarded a $10,774,322 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to The Trustees of Columbia University in the City of New York. The grant aims to place patients impacted by Alzheimer's disease (AD) and related dementias (ADRD) at the center of the research in order to better tailor risk prediction, enable individualized prevention, and improve clinical outcomes and management. The project will federate a multi-ethnic 3-city...
The federal Cooperative Agreement award U01AG084547, provided by the National Institute on Aging under the Aging Research grant program (CFDA 93.866), will contribute genomic data and conduct research on cognitive function in the Mexican Teachers Cohort (MTC). The $5,448,356 award will enable Rush University Medical Center, the prime awardee, to: Collect and process genetic data (GWAS and whole genome sequencing) from nearly 20,000 MTC participants aged 55 and older, and Perform analyses to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,205,827.00 to The University of Texas Southwestern Medical Center to examine the role of environmental exposures as a risk factor for Alzheimer's disease (AD) among different racial/ethnic populations. The project will utilize blood samples from 3,000 participants in the ongoing Health & Aging Brain Study - Health Disparities Study to investigate the "exposome" (overall...
The National Institute on Aging (NIA) awarded a $3,699,536 Project Grant (CFDA 93.866 - Aging Research) to the University of Southern California (USC) to investigate the relationship between education and Alzheimer's disease and related dementias (ADRD). The project leverages the International Genomic Studies of Dementia Consortium (IGEMS) to examine how country, birth cohort, and gender disparities in access to education and occupation impact cognitive outcomes, including ADRD risk. The...

The federal Project Grant award R01AG082056 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The $1,199,134 grant, awarded on June 1, 2024, supports a collaborative study on the social epigenetics of Alzheimer's disease and related dementias in Latin American countries.

The project aims to expand dementia research in Latin America by leveraging an existing multi-partner REDLAT cohort study to identify shared and distinct epigenetic biomarkers associated with Alzheimer's disease and frontotemporal dementia. The research team, led by the Weill Medical College of Cornell University, will collect and analyze epigenetic data from 2,000 Latino participants to investigate the interactions between social determinants of health and epigenetic changes related to dementia presentation. This research will inform regionally-tailored strategies to address dementia disparities in Latin American populations.

The project involves several sub-awards to international partners, including the Pontificia Universidad Javeriana in Argentina, Universidad Adolfo Ibanez in Chile, and Universidad de Antioquia in Colombia, to coordinate data collection, genomic and epigenetic analyses, and clinical assessments across the Latin American study sites.

Generated 4/29/25, 4:06 AM